Activities per year
we propose to develop radiolabelled single domain antibodies (sdAbs) as theranostics to identify biomarkers with in vivo molecular imaging in the tumour and its environment.
|Effective start/end date||1/07/20 → 30/06/23|
Flemish discipline codes
- Nuclear imaging
- single domain antibody fragments
- nuclear imaging
- targeted radionuclide therapy